Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07326553 · ClinicalTrials.gov registry record · Phase 4

Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

A Phase 4 study of Diabete Mellitus and Foot Ulcer Chronic, sponsored by BioXTek.

Recruiting
Registry status
Phase 4
Development phase
30
Enrollment target
2
Study locations

NCT07326553 is a Phase 4 study of Diabete Mellitus and Foot Ulcer Chronic that is actively recruiting participants, run by BioXTek. The registered enrollment target is 30 participants, below the 203-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07326553, a Phase 4 study of Diabete Mellitus and Foot Ulcer Chronic, is actively recruiting participants, sponsored by BioXTek.

RECRUITING
Registry status
Phase 4
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

Evaluation of Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

Interventions

  • BIOLOGICAL Placental Membrane

Study Locations (2)

Arizona

  • Axsendo - Phoenix

Texas

  • Axsendo Clinical Research - Houston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-12-01
Est. Completion 2026-12-31
Phase Phase 4

Sponsor

BioXTek

1 total trials

What the Registry Record Tells You About NCT07326553

The ClinicalTrials.gov registry entry for NCT07326553 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 203-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (85% lower). The listed sponsor is BioXTek, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabete Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Placental Membrane is the first listed.

NCT07326553 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Texas.

Frequently Asked Questions

What is clinical trial NCT07326553 about?

NCT07326553 is a clinical study titled "Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing". Evaluation of Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

What is the current status of trial NCT07326553?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2025-12-01. Estimated completion is 2026-12-31.

What conditions does trial NCT07326553 study?

This clinical trial studies the following conditions: Diabete Mellitus, Foot Ulcer Chronic.

What interventions are being tested in trial NCT07326553?

The interventions under investigation include: Placental Membrane (BIOLOGICAL).

Who is sponsoring clinical trial NCT07326553?

This trial is sponsored by BioXTek, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07326553 being conducted?

This trial has 2 study locations across Arizona, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabete Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.